List of bibliographic references indexed by human
Number of relevant bibliographic references: 1520.
[20-40] [
0 - 20][
0 - 50][
40-60]
| Ident. | Authors (with country if any) | Title |
|---|
| 000066 (2020) |
Naidi Yang [République populaire de Chine] ; Han-Ming Shen [République populaire de Chine] | Targeting the Endocytic Pathway and Autophagy Process as a Novel Therapeutic Strategy in COVID-19 |
| 000071 (2020) |
Ning Wang [États-Unis] ; Jian Shang [États-Unis] ; Shibo Jiang [États-Unis, République populaire de Chine] ; Lanying Du [États-Unis] | Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses |
| 000073 (2020) |
Mushtaq Hussain [Pakistan] ; Nusrat Jabeen [Pakistan] ; Fozia Raza [Pakistan] ; Sanya Shabbir [Pakistan] ; Ayesha A. Baig [Pakistan] ; Anusha Amanullah [Pakistan] ; Basma Aziz [Pakistan] | Structural variations in human ACE2 may influence its binding with SARS-CoV-2 spike protein. |
| 000076 (2020) |
Khalid Al-Ahmadi [Arabie saoudite] ; Mohammed Alahmadi [Arabie saoudite] ; Ali Al-Zahrani [Arabie saoudite] | Spatial association between primary Middle East respiratory syndrome coronavirus infection and exposure to dromedary camels in Saudi Arabia. |
| 000085 (2020) |
Afnan A. Degnah [Arabie saoudite] ; Sawsan S. Al-Amri [Arabie saoudite] ; Ahmed M. Hassan [Arabie saoudite] ; Abdulrahman S. Almasoud [Arabie saoudite] ; Manar Mousa [Arabie saoudite] ; Sarah A. Almahboub [Arabie saoudite] ; Rowa Y. Alhabbab [Arabie saoudite] ; Ahmed A. Mirza [Arabie saoudite] ; Salwa I. Hindawi [Arabie saoudite] ; Naif Khalaf Alharbi [Arabie saoudite] ; Esam I. Azhar [Arabie saoudite] ; Anwar M. Hashem [Arabie saoudite] | Seroprevalence of MERS-CoV in healthy adults in western Saudi Arabia, 2011–2016 |
| 000091 (2020) |
Abdo A. Elfiky | Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study |
| 000097 (2020) |
Shuntong Kang [République populaire de Chine] ; Wenyao Peng [République populaire de Chine] ; Yuhao Zhu [République populaire de Chine] ; Shiyao Lu [République populaire de Chine] ; Min Zhou [République populaire de Chine] ; Wei Lin [République populaire de Chine] ; Wenfang Wu [République populaire de Chine] ; Shu Huang [République populaire de Chine] ; Liping Jiang [République populaire de Chine] ; Xuan Luo [République populaire de Chine] ; Meichun Deng [République populaire de Chine] | Recent progress in understanding 2019 novel coronavirus (SARS-CoV-2) associated with human respiratory disease: detection, mechanisms and treatment |
| 000098 (2020) |
Thanigaimalai Pillaiyar [Allemagne] ; Sangeetha Meenakshisundaram [Inde] ; Manoj Manickam [Inde] | Recent discovery and development of inhibitors targeting coronaviruses |
| 000104 (2020) |
James Segars [États-Unis] ; Quinton Katler [Géorgie (pays)] ; Dana B. Mcqueen [États-Unis] ; Alexander Kotlyar [États-Unis] ; Tanya Glenn [États-Unis] ; Zac Knight [États-Unis] ; Eve C. Feinberg [États-Unis] ; Hugh S. Taylor [États-Unis] ; James P. Toner [Géorgie (pays)] ; Jennifer F. Kawwass [Géorgie (pays)] | Prior and Novel Coronaviruses, COVID-19, and Human Reproduction: What Is Known? |
| 000111 (2020) |
David A. Schwartz [États-Unis] ; Ashley L. Graham | Potential Maternal and Infant Outcomes from Coronavirus 2019-nCoV (SARS-CoV-2) Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections |
| 000113 (2020) |
So-Yong Kwon [Corée du Sud] ; Eun-Jin Kim [Corée du Sud] ; Yu Soek Jung [Corée du Sud] ; Jin Sung Jang [Corée du Sud] ; Nam-Sun Cho [Corée du Sud] | Post-donation COVID-19 identification in blood donors. |
| 000115 (2020) |
Frederick M. Burkle | Political Intrusions into the International Health Regulations Treaty and Its Impact on Management of Rapidly Emerging Zoonotic Pandemics: What History Tells Us. |
| 000116 (2020) |
| Pneumonia Caused by Emerging Viral Agents |
| 000118 (2020) |
Balamurugan Shanmugaraj [Thaïlande] ; Konlavat Siriwattananon [Thaïlande] ; Kittikhun Wangkanont [Thaïlande] ; Waranyoo Phoolcharoen [Thaïlande] | Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19). |
| 000122 (2020) |
James Lyons-Weiler | Pathogenic priming likely contributes to serious and critical illness and mortality in COVID-19 via autoimmunity |
| 000123 (2020) |
Jia Liu [République populaire de Chine] ; Xin Zheng [République populaire de Chine] ; Qiaoxia Tong [République populaire de Chine] ; Wei Li [République populaire de Chine] ; Baoju Wang [République populaire de Chine] ; Kathrin Sutter [Allemagne] ; Mirko Trilling [Allemagne] ; Mengji Lu [Allemagne] ; Ulf Dittmer [Allemagne] ; Dongliang Yang [République populaire de Chine] | Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV. |
| 000129 (2020) |
Zachary J. Sandler [États-Unis] ; Mason R. Firpo [États-Unis] ; Oreoluwa S. Omoba [États-Unis] ; Michelle N. Vu [États-Unis] ; Vineet D. Menachery [États-Unis] ; Bryan C. Mounce [États-Unis] | Novel ionophores active against La Crosse virus identified through rapid antiviral screening. |
| 000131 (2020) |
S A Meo [Arabie saoudite] ; A M Alhowikan ; T. Al-Khlaiwi ; I M Meo ; D M Halepoto ; M. Iqbal ; A M Usmani ; W. Hajjar ; N. Ahmed | Novel coronavirus 2019-nCoV: prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV. |
| 000135 (2020) |
Shibo Jiang [République populaire de Chine] ; Christopher Hillyer [États-Unis] ; Lanying Du [États-Unis] | Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses. |
| 000138 (2020) |
Chek Meng Poh [République populaire de Chine] ; Jian Zheng [États-Unis] ; Rudragouda Channappanavar [États-Unis] ; Zi Wei Chang [Singapour] ; Thi H. O. Nguyen [Australie] ; Laurent Rénia [Singapour] ; Katherine Kedzierska [Australie] ; Stanley Perlman [États-Unis] ; Leo L. M. Poon [République populaire de Chine] | Multiplex Screening Assay for Identifying Cytotoxic CD8+ T Cell Epitopes |
| 000140 (2020) |
Xiaowei Li [République populaire de Chine] ; Manman Geng [République populaire de Chine] ; Yizhao Peng [République populaire de Chine] ; Liesu Meng [République populaire de Chine] ; Shemin Lu [République populaire de Chine] | Molecular immune pathogenesis and diagnosis of COVID-19 |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i -k "human"
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i \
-Sk "human" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= MersV1
|flux= Main
|étape= Exploration
|type= indexItem
|index= AbsEn.i
|clé= human
}}
| This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021 |  |
